Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue SUPPL. 1, 2007, Pages

  Kreuz, Jens ^a   Balta, Osman ^a   Liliegren, Nora ^b   Mellert, Fritz ^a   Esmailzadeh, Bahman ^a   Nickenig, Georg ^a   Schwab, Jörg Otto ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MEDTRONIC INC   (United States)

Author keywords

Implantable cardioverter defibrillator; Primary prevention; Sudden cardiac death; Ventricular tachyarrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; SUDDEN DEATH; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 33846296628     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00621.x     Document Type: Article

References (7)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237
3. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003; 5:381-389.
4. Backenkohler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, et al. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest. J Cardiovasc Electrophysiol 2005; 16:478-482
5. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA 2006; 295:165-171.
6. Morgan JM, Sterns LD, Hanson JL, Ousdigian KT, Otterness MF, Wilkoff BL. A trial design for evaluation of emperic programming of implantable cardioverter defibrillators to improve patient management. Curr Control Trials Cardiovasc Med 2004;5:12.
7. Sterns LD, Wilkoff BL, Morgan JM, Ousdigian KT, Wang ZJ, Peterson BJ, Wilson RD. Can a standardized ICD-programming approach match physician tailored programming in preventing shocks post-ICD implantation (abstract). Heart Rhythm 2005;2:S126.